Regular vs Clear Liquid Diet for Pancreatitis
Trial Summary
What is the purpose of this trial?
Acute pancreatitis is among the most common gastroenterology diagnosis in the United States, and represents a large economic burden to the United States health system. While recent guidelines agree early feeding shortens length of stay, these guidelines fail to provide recommendations on optimal diet to start leaving diet type to clinician discretion. Therefore, the aim is to assess the comparative efficacy of full calorie regular diet (RD) versus clear liquid diet (CLD) on length of hospital stay (LOHS) for mild to moderate acute pancreatitis (AP). The study population will target mild to moderate acute pancreatitis patients who can tolerate eating in a single institution. The primary end point will focus on LOHS, and secondary end points will include Pancreatic Activity Scoring System, side effects and readmission.
Research Team
James Buxbaum, MD
Principal Investigator
Principal Investigator
Eligibility Criteria
This trial is for adults over 18 with mild to moderate acute pancreatitis, confirmed by specific diagnostic criteria. It's not for pregnant or breastfeeding women, those unable to consent, transferred from other hospitals, with chronic/severe pancreatitis, certain etiologies like hypertriglyceridemia or trauma, and those who can't eat orally due to other medical issues.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Clear Liquid Diet (Behavioural Intervention)
- Regular diet (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
Dr. Samir A.
University of Southern California
Chief Executive Officer since 2024
PhD in Molecular Biology from the University of Southern California
Dr. Chung
University of Southern California
Chief Medical Officer since 2016
MD from UC San Diego